- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04881097
Cognitive Function and Health-related Quality of Life After Neuro-intensive Care (COGNI)
November 3, 2022 updated by: Kirsten Moller, Rigshospitalet, Denmark
Cognitive Function and Health-related Quality of Life After Neuro-intensive Care: An Observational Multicenter Cohort Study
The study will provide information on cognitive impairment and Health related quality of life in patients surviving 12 months after acute brain injury, generate a hypothesis of useful variables to predict cognitive impairment or low levels of HRQoL, and potentially inform interventions for the prevention and treatment of cognitive impairment following neuro-ICU stay.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The aim is to 1) measure the frequency and extent of cognitive impairment after acute brain injury at six and 12-months after neuro-Intensive care unit (ICU) admission 2) explore the association between cognitive impairment at six and 12 months after ICU admission with the following potential risk factors: duration of ICU delirium (days), duration of sepsis (days), duration of post traumatic amnesia (days) and the severity of brain injury (initial Glasgow Coma Scale , 3) describe Health related quality of life, functional disability and frailty at six and 12 after ICU admission and 4) explore the association between the functional disability, frailty and health-related quality of life at 12 months after ICU admission
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 110 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adults with acute brain injury from traumatic brain injury, spontaneous intracranial hemorrhage, or ischemic stroke with a Neuro ICU stay
Description
Inclusion Criteria:
- Traumatic brain injury
- Spontaneous intracranial hemorrhage
- Ischemic stroke
- An anticipated stay in the neuro-ICU for 48 hours or longer.
Exclusion Criteria:
- Persistent coma defined as Richmond Agitation-Sedation Scale (RASS) -5 to -3 throughout the neuro-ICU stay
- Congenital brain injury
- Suspected pre-existing Cognitive impairment (Informant Questionnaire on cognitive decline in the elderly (IQCODE): 3.3 or more) (regardless of cause)
- Permanent residence outside Denmark
- Inability to communicate in Danish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Global cognitive function
Time Frame: from baseline to 6 months after ICU admission
|
measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15).
Higher scores indicate better cognitive functioning.
|
from baseline to 6 months after ICU admission
|
Change in Global cognitive function
Time Frame: from baseline to 12 months after ICU admission
|
measured by The Repeatable Battery for the Assessment of Neuropsychological Status, Overall score (mean 100; SD=15).
Higher scores indicate better cognitive functioning.
|
from baseline to 12 months after ICU admission
|
Change in Executive function
Time Frame: from baseline to 6 months after ICU admission
|
measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function
|
from baseline to 6 months after ICU admission
|
Change in Executive function
Time Frame: from baseline to 12 months after ICU admission
|
measured by Trail Making Test B, Score indicate time in seconds to complete task, the higher speed (less seconds) indicates higher executive function
|
from baseline to 12 months after ICU admission
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Health related quality of life after brain injury
Time Frame: from baseline to 6 months after ICU admission
|
measured with a disease specific questionnaire:Quality of Life after Brain Injury overall scale (QOLIBRI-OS).
Scores are from 0-100, the higher the score the more quality of life.
|
from baseline to 6 months after ICU admission
|
Change in Health related quality of life after brain injury
Time Frame: from baseline to 12 months after ICU admission
|
measured with a disease specific questionnaire:Quality of Life after Brain Injury overall scale (QOLIBRI-OS).
Scores are from 0-100, the higher the score the more quality of life.
|
from baseline to 12 months after ICU admission
|
Delirium
Time Frame: during the procedure (ICU stay) up to 30 days
|
measured by Confusion measured by CAM-ICU or Intensive Care Delirium Screening Checklist (ICDSC).
|
during the procedure (ICU stay) up to 30 days
|
Change in Disability after head injury/nontraumatic acute brain insults I
Time Frame: from baseline to 6 months after ICU admission
|
measured by Glasgow outcome scale extended (GOSE).
Scores from 1 to 8, higher scores indicate less disability
|
from baseline to 6 months after ICU admission
|
Change in Disability after head injury/nontraumatic acute brain insults I
Time Frame: from baseline to 12 months after ICU admission
|
measured by Glasgow outcome scale extended (GOSE).
Scores from 1 to 8, higher scores indicate less disability
|
from baseline to 12 months after ICU admission
|
Change in Disability after head injury/nontraumatic acute brain insults II
Time Frame: from baseline to 6 months after ICU admission
|
measured by Extended disability rating scale (DRS).
Scores from 0 to 29, the higher the score the more disability
|
from baseline to 6 months after ICU admission
|
Change in Disability after head injury/nontraumatic acute brain insults II
Time Frame: from baseline to 12 months after ICU admission
|
measured by Extended disability rating scale (DRS).
Scores from 0 to 29, the higher the score the more disability
|
from baseline to 12 months after ICU admission
|
Change in Frailty
Time Frame: baseline to 6 months after ICU admission
|
measured by the Clinical Frailty Scale (CFS).
Scale is from 1 to 9 ( the higher score the more frail).
|
baseline to 6 months after ICU admission
|
Change in Frailty
Time Frame: baseline to 12 months after ICU admission
|
measured by the Clinical Frailty Scale (CFS).
Scale is from 1 to 9 ( the higher score the more frail).
|
baseline to 12 months after ICU admission
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Suzanne F Herling, Ph.D, Rigshospitalet, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2021
Primary Completion (Anticipated)
August 1, 2024
Study Completion (Anticipated)
August 1, 2025
Study Registration Dates
First Submitted
April 22, 2021
First Submitted That Met QC Criteria
May 5, 2021
First Posted (Actual)
May 11, 2021
Study Record Updates
Last Update Posted (Actual)
November 8, 2022
Last Update Submitted That Met QC Criteria
November 3, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Wounds and Injuries
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Craniocerebral Trauma
- Trauma, Nervous System
- Cognition Disorders
- Memory Disorders
- Brain Injuries
- Cognitive Dysfunction
- Amnesia
Other Study ID Numbers
- NNF 20OC0064760
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Zagazig UniversityRecruitingSepsis-associated EncephalopathyEgypt
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
Clinical Trials on no intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of PittsburghCompletedChronic Low Back PainUnited States